These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 35209071
21. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D, Demers LM. Int J Cancer; 1997 Jan 17; 70(2):175-82. PubMed ID: 9009157 [Abstract] [Full Text] [Related]
22. Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus. Li W, Luo L, Shi W, Yin Y, Gao S. Environ Toxicol; 2021 Feb 17; 36(2):267-275. PubMed ID: 33009882 [Abstract] [Full Text] [Related]
23. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T, Wang C, Liu Q, Meng Q, Sun H, Huo X, Sun P, Peng J, Liu Z, Yang X, Liu K. Cancer Biol Ther; 2015 Feb 17; 16(1):106-14. PubMed ID: 25482933 [Abstract] [Full Text] [Related]
24. Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Liu K, Guo L, Miao L, Bao W, Yang J, Li X, Xi T, Zhao W. Anticancer Drugs; 2013 Jun 17; 24(5):494-503. PubMed ID: 23511428 [Abstract] [Full Text] [Related]
25. Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. Wang J, Liu L, Qiu H, Zhang X, Guo W, Chen W, Tian Y, Fu L, Shi D, Cheng J, Huang W, Deng W. PLoS One; 2013 Jun 17; 8(5):e63872. PubMed ID: 23737956 [Abstract] [Full Text] [Related]
26. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y, Lin ZM, Ge N, Zhang DL, Huang J, Kong F. Am J Chin Med; 2015 Jun 17; 43(7):1471-86. PubMed ID: 26503559 [Abstract] [Full Text] [Related]
27. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation. Zhang ZL, Jiang QC, Wang SR. Breast Cancer; 2018 Mar 17; 25(2):233-242. PubMed ID: 29181822 [Abstract] [Full Text] [Related]
28. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment. Prasad S, Yadav VR, Sung B, Gupta SC, Tyagi AK, Aggarwal BB. Oncotarget; 2016 Mar 15; 7(11):13182-96. PubMed ID: 26909608 [Abstract] [Full Text] [Related]
29. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM, Sethi G. J Mol Med (Berl); 2011 Jul 15; 89(7):713-27. PubMed ID: 21465181 [Abstract] [Full Text] [Related]
30. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Li J, Liang X, Yang X. Oncol Rep; 2012 Aug 15; 28(2):501-10. PubMed ID: 22641480 [Abstract] [Full Text] [Related]
31. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells. Hu D, Li M, Su J, Miao K, Qiu X. Genet Test Mol Biomarkers; 2019 Mar 15; 23(3):156-165. PubMed ID: 30807260 [Abstract] [Full Text] [Related]
32. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells. Yang LJ, Tang Q, Wu J, Chen Y, Zheng F, Dai Z, Hann SS. J Exp Clin Cancer Res; 2016 Mar 31; 35():59. PubMed ID: 27036874 [Abstract] [Full Text] [Related]
33. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Thomas T, Thomas TJ. Breast Cancer Res Treat; 1994 Feb 31; 29(2):189-201. PubMed ID: 8012036 [Abstract] [Full Text] [Related]
34. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7. Fang XJ, Jiang H, Zhao XP, Jiang WM. BMC Cancer; 2011 Jul 12; 11():290. PubMed ID: 21749678 [Abstract] [Full Text] [Related]
35. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin. Xue C, Wang C, Sun Y, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Ma X, Peng J, Liu K. Oncotarget; 2017 Jan 31; 8(5):8622-8632. PubMed ID: 28052008 [Abstract] [Full Text] [Related]
36. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Life Sci; 2021 Jan 15; 265():118854. PubMed ID: 33278391 [Abstract] [Full Text] [Related]
37. A pentacyclic triterpene natural product, ursolic acid and its prodrug US597 inhibit targets within cell adhesion pathway and prevent cancer metastasis. Xiang L, Chi T, Tang Q, Yang X, Ou M, Chen X, Yu X, Chen J, Ho RJ, Shao J, Jia L. Oncotarget; 2015 Apr 20; 6(11):9295-312. PubMed ID: 25823660 [Abstract] [Full Text] [Related]
38. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. Chen YJ, Kuo CD, Chen SH, Chen WJ, Huang WC, Chao KS, Liao HF. PLoS One; 2012 Apr 20; 7(5):e37006. PubMed ID: 22615870 [Abstract] [Full Text] [Related]
39. The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly. Chen H, Li S, Wang S, Li W, Bao N, Ai W. Bioorg Med Chem Lett; 2018 Aug 01; 28(14):2490-2492. PubMed ID: 29903663 [Abstract] [Full Text] [Related]
40. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver. He W, Shi F, Zhou ZW, Li B, Zhang K, Zhang X, Ouyang C, Zhou SF, Zhu X. Drug Des Devel Ther; 2015 Aug 01; 9():3989-4104. PubMed ID: 26347199 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]